Coronavirus Latest News

Pfizer set to allow cheaper versions of its Covid-19 pill to improve access

Pfizer Inc reached a licensing agreement that will allow generic-drug manufacturers to produce inexpensive versions of its Covid-19 pill for 95 low- and middle-income countries, following a similar move by Merck & Co.In a statement on Tuesday, Pfizer said it has signed an agreement with the United Nations-backed Medicines Patent Pool to license the experimental pill, once it is authorised by regulators, to generic companies that can supply it to countries that account for roughly 53 per cent of…

Read the original article at South China Morning Post

Related Articles

Back to top button